It’s February, so open enrollment for the Affordable Care Act is over. We’re getting the first glimpses of how sign-ups are shaking out after the expiration of enhanced subsidies…
PTC Therapeutics said it cannot resolve differences it has with the FDA in interpreting clinical…
The PERM program measures improper payments in Medicaid through cyclical audits of state Medicaid programs….
LeeAnn Miller, PharmD, of Cencora’s Accelerate Pharmacy Solutions, discusses changes involving specialty pharmacy, home infusion,…
It’s February, so open enrollment for the Affordable Care Act is over. We’re getting the first glimpses of how sign-ups are shaking out after the expiration of enhanced subsidies that helped most people with their premium costs. While more Americans enrolled than some policy analysts had expected, the number was still 1.2 million below what it was at the same time last year. And experts say it will be months until the numbers are final. The timing will depend on how many of those people who…
PTC Therapeutics said it cannot resolve differences it has with the FDA in interpreting clinical trial data for Translarna, a drug it developed for Duchenne muscular dystrophy. The rare disease drug developer’s decision to withdraw Translarna’s FDA submission comes nearly a year after a negative European regulatory decision for the drug. The post PTC Therapeutics…
The PERM program measures improper payments in Medicaid through cyclical audits of state Medicaid programs. This brief explains the PERM program and its three component error rates as well as upcoming changes to PERM and possible state impacts.
LeeAnn Miller, PharmD, of Cencora’s Accelerate Pharmacy Solutions, discusses changes involving specialty pharmacy, home infusion, and 340B
VBC models deliver significant benefits for CKD management by coordinating medical, behavioral, and social support through multidisciplinary teams. This approach enables providers to personalize care, address barriers to access, and use data-driven strategies to identify and prioritize high-risk patients. The post Closing the CKD Care Gap with Value-Based Care Models appeared first on MedCity News.
Expert opinions: Will MFN reduce US drug prices?Robots in maternity care.What drives company decisions on new medicine launches and UK investment?Incorporating dynamic pricing into HEOR models (dynamicpv)Tale of 2 value sets.How to handle the lows? Honesty.Integrity in journalism: Giannis edition.
Giving healthcare teams powerful AI tools without training undermines their ability to use potentially system-changing tools safely and effectively. The post AI Can’t Improve Healthcare if Clinicians and Staff Aren’t Trained to Use, Orchestrate It appeared first on MedCity News.
Health policy has never looked so flirtatious. Every year, our readers send us valentines that make us swoon, laugh, and occasionally clutch our insurance cards. And in 2026, you did not hold back. You wrote about overcharging, rising insurance, AI in health care, and more. Here are some of our favorites, starting with the poem that stole…
The Trump administration has unveiled a sweeping set of regulatory proposals that would substantially change health plan offerings on the Affordable Care Act marketplace next year, aiming, it says, to provide more choice and lower premiums. But it also proposes sharply raising some annual out-of-pocket costs — to more than $27,600 for one type of…
One year after taking charge of the nation’s health department, Health and Human Services Secretary Robert F. Kennedy Jr. hasn’t held true to many of the promises he made while appealing to U.S. senators concerned about the longtime anti-vaccine activist’s plans for the nation’s care. Kennedy squeaked through a narrow Senate vote to be confirmed…
